{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T04:27:19Z","timestamp":1772252839059,"version":"3.50.1"},"reference-count":22,"publisher":"Pharmaceutical Society of Japan","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2026,2,26]]},"DOI":"10.1248\/bpb.b25-00345","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T22:09:23Z","timestamp":1772057363000},"page":"392-399","source":"Crossref","is-referenced-by-count":0,"title":["Interlaboratory Method Validation for Determination of Polysorbate 80 for Analysis of mAbs"],"prefix":"10.1248","volume":"49","author":[{"given":"Xiaojuan","family":"Yu","sequence":"first","affiliation":[{"name":"Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, National Institutes for Food and Drug Control, Beijing 102629, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feiyu","family":"Wang","sequence":"additional","affiliation":[{"name":"Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, National Institutes for Food and Drug Control, Beijing 102629, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanfei","family":"Yu","sequence":"additional","affiliation":[{"name":"Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, National Institutes for Food and Drug Control, Beijing 102629, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Wang","sequence":"additional","affiliation":[{"name":"Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, National Institutes for Food and Drug Control, Beijing 102629, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Lehtimaki M, Ortega-Rodriguez U, Centola G, Rao VA. Reduced IgG1 antibody left-twisted antiparallel \u03b2-sheet structure stability occurs under metal-catalyzed oxidation conditions in the presence of polysorbates. <i>Mol. Pharm.<\/i>, <b>22<\/b>, 2623\u20132638 (2025).","DOI":"10.1021\/acs.molpharmaceut.5c00034"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Honemann MN, Wendler J, Graf T, Bathke A, Bell CH. Monitoring polysorbate hydrolysis in biopharmaceuticals using a QC-ready free fatty acid quantification method. <i>J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.<\/i>, <b>1116<\/b>, 1\u20138 (2019).","DOI":"10.1016\/j.jchromb.2019.03.030"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Zhang S, Riccardi C, Carlson D, Kamen D, Graham KS, Shameem M, Bak H, Xiao H, Li N. Prediction of long-term polysorbate degradation according to short-term degradation kinetics. <i>MAbs<\/i>, <b>15<\/b>, 2232486 (2023).","DOI":"10.1080\/19420862.2023.2232486"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Desai R, Jain R, Dandekar P. Surfactants reduce aggregation of monoclonal antibodies in cell culture medium with improvement in performance of mammalian cell culture. <i>Biotechnol. Prog.<\/i>, <b>39<\/b>, e3370 (2023).","DOI":"10.1002\/btpr.3370"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Z\u00fcrcher D, Caduff S, Aurand L, Capasso Palmiero U, Wuchner K, Arosio P. Comparison of the protective effect of polysorbates, poloxamer and brij on antibody stability against different interfaces. <i>J. Pharm. Sci.<\/i>, <b>112<\/b>, 2853\u20132862 (2023).","DOI":"10.1016\/j.xphs.2023.06.004"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Felix MN, Waerner T, Lakatos D, Reisinger B, Fischer S, Garidel P. Polysorbates degrading enzymes in biotherapeutics\u2014a current status and future perspectives. <i>Front. Bioeng. Biotechnol.<\/i>, <b>12<\/b>, 1490276 (2025).","DOI":"10.3389\/fbioe.2024.1490276"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Z\u00fcrcher D, Wuchner K, Arosio P. Mitigation strategies against antibody aggregation induced by oleic acid in liquid formulations. <i>Mol. Pharm.<\/i>, <b>21<\/b>, 5761\u20135771 (2024).","DOI":"10.1021\/acs.molpharmaceut.4c00754"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Hipper E, Diederichs T, Kaiser W, Lehmann F, Buske J, Hinderberger D, Garidel P. Visible light triggers the formation of reactive oxygen species in monoclonal antibody formulations. <i>Int. J. Pharm.<\/i>, <b>661<\/b>, 124392 (2024).","DOI":"10.1016\/j.ijpharm.2024.124392"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Kishore RSK, Kiese S, Fischer S, Pappenberger A, Grauschopf U, Mahler H-C. The degradation of polysorbates 20 and 80 and its potential impact on the stability of biotherapeutics. <i>Pharm. Res.<\/i>, <b>28<\/b>, 1194\u20131210 (2011).","DOI":"10.1007\/s11095-011-0385-x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Tomlinson A, Demeule B, Lin B, Yadav S. Polysorbate 20 degradation in biopharmaceutical formulations: quantification of free fatty acids, characterization of particulates, and insights into the degradation mechanism. <i>Mol. Pharm.<\/i>, <b>12<\/b>, 3805\u20133815 (2015).","DOI":"10.1021\/acs.molpharmaceut.5b00311"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Mondal B, Kote M, Lunagariya C, Patel M. Development of a simple high performance liquid chromatography (HPLC)\/evaporative light scattering detector (ELSD) method to determine Polysorbate 80 in a pharmaceutical formulation. <i>Saudi Pharm. J.<\/i>, <b>28<\/b>, 325\u2013328 (2020).","DOI":"10.1016\/j.jsps.2020.01.012"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Bai L, Zhang Y, Zhang C, Lu Y, Li Z, Huang G, Meng B. Investigation of excipients impact on polysorbate 80 degradation in biopharmaceutical formulation buffers. <i>J. Pharm. Biomed. Anal.<\/i>, <b>233<\/b>, 115496 (2023).","DOI":"10.1016\/j.jpba.2023.115496"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Doyle M, Barnes A, Larson NR, Liu H, Yi L. Development of UPLC-UV-ELSD method for fatty acid profiling in polysorbate 80 and confirmation of the presence of conjugated fatty acids by mass spectrometry, UV absorbance and proton nuclear magnetic resonance spectroscopy. <i>J. Pharm. Sci.<\/i>, <b>112<\/b>, 2393\u20132403 (2023).","DOI":"10.1016\/j.xphs.2023.06.001"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Zegota MM, Schuster G, De Pra M, Mullner T, Menzen T, Steiner F, Hawe A. High throughput multidimensional liquid chromatography approach for online protein removal and characterization of polysorbates and poloxamer in monoclonal antibody formulations. <i>J. Chromatogr. A<\/i>, <b>1720<\/b>, 464777 (2024).","DOI":"10.1016\/j.chroma.2024.464777"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Schilling K, Pawellek R, Lovejoy K, Muellner T, Holzgrabe U. Influence of charged aerosol detector instrument settings on the ultra-high-performance liquid chromatography analysis of fatty acids in polysorbate 80. <i>J. Chromatogr. A<\/i>, <b>1576<\/b>, 58\u201366 (2018).","DOI":"10.1016\/j.chroma.2018.09.031"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Hewitt D, Alvarez M, Robinson K, Ji J, Wang YJ, Kao YH, Zhang T. Mixed-mode and reversed-phase liquid chromatography-tandem mass spectrometry methodologies to study composition and base hydrolysis of polysorbate 20 and 80. <i>J. Chromatogr. A<\/i>, <b>1218<\/b>, 2138\u20132145 (2011).","DOI":"10.1016\/j.chroma.2010.09.057"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Magnusson LE, Risley DS, Koropchak JA. Aerosol-based detectors for liquid chromatography. <i>J. Chromatogr. A<\/i>, <b>1421<\/b>, 68\u201381 (2015).","DOI":"10.1016\/j.chroma.2015.07.045"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Schilling K, Holzgrabe U. Recent applications of the charged aerosol detector for liquid chromatography in drug quality control. <i>J. Chromatogr. A<\/i>, <b>1619<\/b>, 460911 (2020).","DOI":"10.1016\/j.chroma.2020.460911"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Shende N, Karale A, Bhagade S, Gulhane A, Bore P, Marathe P, Chakraborty S, Mallya AD, Dhere RM. Evaluation of a sensitive GC-MS method to detect polysorbate 80 in vaccine preparation. <i>J. Pharm. Biomed. Anal.<\/i>, <b>183<\/b>, 113126 (2020).","DOI":"10.1016\/j.jpba.2020.113126"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Hewitt D, Zhang T, Kao Y. Quantitation of polysorbate 20 in protein solutions using mixed-mode chromatography and evaporative light scattering detection. <i>J. Chromatogr. A<\/i>, <b>1215<\/b>, 156\u2013160 (2008).","DOI":"10.1016\/j.chroma.2008.11.017"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Paschen CA, Klemm D, Graf T, Kopf R, Pinto C, Muller C, Bell CH, Pfaff J. Simultaneous quantification of polysorbate 20 and poloxamer 188 in biopharmaceutical formulations using evaporative light scattering detection. <i>J. Pharm. Biomed. Anal.<\/i>, <b>192<\/b>, 113640 (2021).","DOI":"10.1016\/j.jpba.2020.113640"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Zhang R, Wang Y, Tan L, Zhang HY, Yang M. Analysis of polysorbate 80 and its related compounds by RP-HPLC with ELSD and MS detection. <i>J. Chromatogr. Sci.<\/i>, <b>50<\/b>, 598\u2013607 (2012).","DOI":"10.1093\/chromsci\/bms035"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/2\/49_b25-00345\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T03:35:25Z","timestamp":1772249725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/2\/49_b25-00345\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b25-00345","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"article-number":"b25-00345"}}